United Therapeutics CorporationSilver Spring, MD, United States (NASDAQ (GS): UTHR)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

United Therapeutics Financial Statements

United Therapeutics Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

United Therapeutics Income Statement

  2007 2006 2005
Revenue ($ mil.) 210.9 159.6 115.9
Gross Profit ($ mil.) 188.7 142.6 103.6
Operating Income ($ mil.) 6.3 29.0 42.9
Total Net Income ($ mil.) 19.9 74.0 65.0
Diluted EPS (Net Income) 0.88 3.06 2.58
More United Therapeutics financial information

United Therapeutics Quarterly Statements

  Quarter Ending Sep 08 Quarter Ending Jun 08 Quarter Ending Mar 08
Revenue ($ mil.) 75.0 68.6 62.0
Gross Profit ($ mil.) 67.3 61.2 55.2
Operating Income ($ mil.) 18.1 19.0 14.8
Total Net Income ($ mil.) 12.6 14.3 11.4
Diluted EPS (Net Income) 0.48 0.60 0.47
More United Therapeutics financial information

United Therapeutics Stock Quote & Chart

12/02/08 16:00:05 EST • NASDAQ • 52.01 • Increased by +0.7600 • Increased by +1.4829 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

United Therapeutics Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 7.92 2.19 0.94
Price/Earnings Ratio 50.57 10.78 10.50
Price/Book Ratio 5.02 1.67 0.89
Price/Cash Flow Ratio 30.10 8.97 5.93
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed United Therapeutics Financial Ratios

United Therapeutics Competitive Intelligence

Actelion Bayer Schering Pharma Gilead Sciences
Annual Sales ($ mil.) 1,317.4 6,286.8 4,230.0
Employees 1,640 25,037 2,979
Market Cap ($ mil.) -- -- 43,201.3

Competitive Landscape